![Jeffrey M. Liebmann](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jeffrey M. Liebmann
Fundador en American Glaucoma Society Foundation .
Cargos activos de Jeffrey M. Liebmann
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Sustained Nano Systems LLC
![]() Sustained Nano Systems LLC Miscellaneous Commercial ServicesCommercial Services Sustained Nano Systems LLC is a company that develops products for post-cataract surgery treatment. The company is based in Westhampton Beach, NY and was founded by Barry M. Libin, who has been the CEO since incorporation. The company's products include dex-sa, which delivers dexamethasone to the subconjunctival space to treat postoperative inflammation and pain, and lat-la, a single extraocular injectable administration of a six-month release prostaglandin analog for glaucoma treatment. The company also develops SNS ret-la, which prevents blood vessel growth for over a year in a standard rabbit model of corneal angiogenesis. | Director/Miembro de la Junta | - | - |
Galimedix Therapeutics, Inc. (Maryland)
![]() Galimedix Therapeutics, Inc. (Maryland) Medical/Nursing ServicesHealth Services Galimedix Therapeutics, Inc. is an ophthalmic pharmaceutical company based in Kensington, MD. Galimedix is focused on developing innovative treatments for various neurodegenerative diseases. The company's lead product, GAL-101, has shown promising results in treating these diseases. The company was founded by Chris Parsons, Andrew Leonard Pearlman, Alexander Gebauer. | Director/Miembro de la Junta | - | - |
Columbia University Irving Medical Center | Director/Miembro de la Junta | - | - |
World Glaucoma Association | Presidente | - | - |
Glaucoma Foundation | Director/Miembro de la Junta | - | - |
New York Society For Clinical Ophthalmology | Presidente | - | - |
New York Glaucoma Research Institute | Fundador | - | - |
Infocus Capital Partners
![]() Infocus Capital Partners Investment ManagersFinance InFocus Capital Partners (InFocus Capital Partners) is a venture capital firm founded in 2016 by Rob Rothman and Ron Weiss. The firm is headquartered in Jericho, New York. | Consultor / Asesor | - | - |
American Glaucoma Society Foundation | Fundador | - | - |
Historial de carrera de Jeffrey M. Liebmann
Antiguos cargos conocidos de Jeffrey M. Liebmann.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
░░░░░░░░ ░░░░░░░░ ░░░░░░░ | ░░░░░░░░░ | - | - |
Estadísticas
Internacional
Estados Unidos | 10 |
Países Bajos | 2 |
Operativa
Director/Board Member | 4 |
President | 3 |
Founder | 2 |
Sectorial
Miscellaneous | 2 |
Finance | 2 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 10 |
---|---|
World Glaucoma Association | |
American Glaucoma Society
![]() American Glaucoma Society Investment Trusts/Mutual FundsMiscellaneous The American Glaucoma Society supports glaucoma specialists and scientists through the advancement of education and research. | Miscellaneous |
Glaucoma Foundation | |
Infocus Capital Partners
![]() Infocus Capital Partners Investment ManagersFinance InFocus Capital Partners (InFocus Capital Partners) is a venture capital firm founded in 2016 by Rob Rothman and Ron Weiss. The firm is headquartered in Jericho, New York. | Finance |
Sustained Nano Systems LLC
![]() Sustained Nano Systems LLC Miscellaneous Commercial ServicesCommercial Services Sustained Nano Systems LLC is a company that develops products for post-cataract surgery treatment. The company is based in Westhampton Beach, NY and was founded by Barry M. Libin, who has been the CEO since incorporation. The company's products include dex-sa, which delivers dexamethasone to the subconjunctival space to treat postoperative inflammation and pain, and lat-la, a single extraocular injectable administration of a six-month release prostaglandin analog for glaucoma treatment. The company also develops SNS ret-la, which prevents blood vessel growth for over a year in a standard rabbit model of corneal angiogenesis. | Commercial Services |
Galimedix Therapeutics, Inc. (Maryland)
![]() Galimedix Therapeutics, Inc. (Maryland) Medical/Nursing ServicesHealth Services Galimedix Therapeutics, Inc. is an ophthalmic pharmaceutical company based in Kensington, MD. Galimedix is focused on developing innovative treatments for various neurodegenerative diseases. The company's lead product, GAL-101, has shown promising results in treating these diseases. The company was founded by Chris Parsons, Andrew Leonard Pearlman, Alexander Gebauer. | Health Services |
Columbia University Irving Medical Center | |
New York Society For Clinical Ophthalmology | |
New York Glaucoma Research Institute | |
American Glaucoma Society Foundation |
- Bolsa de valores
- Insiders
- Jeffrey M. Liebmann
- Experiencia